JOHN MULLIGAN: Open Payments
NPI 1740813120 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 22 payments from 10 companies in 2025. Trend: 2023 $335 · 2024 $380 · 2025 $863
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $404 |
| Smith+Nephew, Inc. | 9 | $185 |
| VentureMed Group, Inc. | 1 | $56 |
| Shockwave Medical, Inc | 2 | $46 |
| Tactile Systems Technology Inc | 1 | $37 |
| Bard Peripheral Vascular, Inc. | 1 | $36 |
| LeMaitre Vascular, Inc. | 1 | $29 |
| Recor Medical Inc | 1 | $24 |
| Advanced Oxygen Therapy Inc. | 1 | $23 |
| Humacyte Global, Inc. | 1 | $23 |
Products named: ACCOLADE SR, COLLAGENASE SANTYL, FLEX Vessel Prep System, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, GRAFIX PL, Flexitouch Plus, LUTONIX Drug Coated Balloon, PRUITT F3 CAROTID SHUNT.
Industry payments across NY — which companies pay providers there.
